(Press-News.org) Contact information: Carrie Strehlau
carrie.strehlau@stjude.org
901-595-2295
St. Jude Children's Research Hospital
Gene therapy bolsters enzyme activity to combat Alzheimer's disease in mice
St. Jude Children's Research Hospital scientists identify enzyme that could lead to better diagnosis and treatment of Alzheimer's disease and related disorders
(MEMPHIS, Tenn.—December 3, 2013) St. Jude Children's Research Hospital scientists have identified an enzyme that can halt or possibly even reverse the build-up of toxic protein fragments known as plaques in the brains of mice with Alzheimer's disease. The research appeared in a recent edition of the scientific journal Nature Communications.
Plaques decreased substantially in mice treated with gene therapy to increase activity of the enzyme neuraminidase 1 (NEU1) in a region of the brain involved in learning and memory. Plaques accumulate between neurons in the brains of Alzheimer's patients and are a hallmark of the disease.
The results raise hopes the enzyme could lead to new methods of diagnosing and treating Alzheimer's disease, a neurodegenerative disorder that causes problems with memory, thinking and behavior. More than 5 million Americans are currently living with the problem. The number is expected to rise as the population ages.
"The findings suggest that down-regulation of NEU1 and a reduced supply of the enzyme may contribute to the development of Alzheimer's disease or similar neurodegenerative disorders in some patients," said the study's corresponding author Alessandra d'Azzo, Ph.D., a member in the St. Jude Department of Genetics. "Among the questions we are asking is whether a therapeutic window exists when the enzyme could be used to halt or even reverse the disease."
NEU1 belongs to a family of enzymes in cells whose job is to dismantle and recycle unneeded proteins and other components. The work is done inside cell structures called lysosomes.
The enzyme is missing or reduced in a rare inherited disorder called sialidosis that can affect children and adolescents. This is the first report linking NEU1 to age-related neurodegenerative disorders like Alzheimer's. In collaboration with the University of California, Davis, D'Azzo and her colleagues have begun checking NEU1 levels in brain tissue of Alzheimer's patients at different stages of the disease.
D'Azzo's long-standing interest in sialidosis and related disorders known as lysosomal storage diseases led to the discovery. The findings include evidence of how the protein fragments that make up the Alzheimer's plaque are deposited outside neurons and how loss of NEU1 possibly contributes to disease progression and spread.
The work was done in a mouse developed in d'Azzo's laboratory that lacked the NEU1 gene. These studies revealed that loss of NEU1 activity was associated with a build-up in lysosomes of the amyloid precursor protein (APP), which they identified as a natural target of the enzyme. Improperly processed, APP is broken into the toxic peptides that form Alzheimer's plaques. Those fragments include amyloid beta peptide 42 (Aβ-42), which researchers suspect play a major role in the Alzheimer's disease process.
Not only did APP accumulate in lysosomes of mice lacking NEU1 but researchers found evidence that the build-up promoted the production of Aβ-42 and other toxic peptides tied to Alzheimer's disease. Aβ-42 was detected in the spinal fluid and hippocampus of mice that lacked NEU1, but not in mice with a functional NEU1 gene. The hippocampus plays a critical role in learning and memory and is the brain region that is often an early casualty of Alzheimer's disease.
Previously, d'Azzo's laboratory discovered that NEU1 directs a process called lysosomal exocytosis. Cells use this process to repair the outer membrane of cells and to selectively expel material in lysosomes. Working with nerve cells growing in culture, investigators reported that the absence of NEU1 was accompanied by an increase in a protein named LAMP1. The protein is a key regulator of lysosomal exocytosis. Increased LAMP1 levels were followed by excessive lysosomal exocytosis in nerve cells, resulting in increased release of Alzheimer-linked peptides from neurons.
Loss of NEU1 also accelerated the disease process in mice bred to mimic early-onset Alzheimer's in humans. Without the enzyme, both APP and the protein fragments that make up plaques accumulated faster in these mice.
But within weeks of using gene therapy to bolster NEU1 activity, d'Azzo's group reported that plaques declined dramatically in the hippocampus of treated mice. Scientists used an altered cold virus as the vector to deliver both the NEU1 and PPCA genes to mouse brain cells. The PPCA protein is required for NEU1 to function properly. The gene therapy vector was developed at St. Jude.
"These results suggest that not only is NEU1 deficiency a risk factor for developing Alzheimer's disease, but that this enzyme could be used to slow or even reverse the disease process," d'Azzo said.
###
The study's first author is Ida Annunziata, Ph.D., a postdoctoral fellow in d'Azzo's laboratory. The other authors are Annette Patterson, Danielle Helton, Huimin Hu, Simon Moshiach and Elida Gomero, all of St. Jude, and Ralph Nixon, of the Nathan S. Kline Institute, Orangeburg, N.Y.
D'Azzo holds the Jewelers for Children Endowed Chair in Genetics and Gene Therapy at St. Jude. The research is funded in part by grants (GM60905 and DK52025) from the National Institutes of Health, the Assisi Foundation of Memphis, the National Tay-Sachs & Allied Disease Association and ALSAC.
St. Jude Media Relations Contacts
Summer Freeman
(desk) (901) 595-3061
(cell) (901) 297-9861
summer.freeman@stjude.org
Carrie Strehlau
(desk) (901) 595-2295
(cell) (901) 297-9875
carrie.strehlau@stjude.org
Gene therapy bolsters enzyme activity to combat Alzheimer's disease in mice
St. Jude Children's Research Hospital scientists identify enzyme that could lead to better diagnosis and treatment of Alzheimer's disease and related disorders
2013-12-04
ELSE PRESS RELEASES FROM THIS DATE:
Screeners miss the really rare stuff
2013-12-04
Screeners miss the really rare stuff
Commonly found objects may be crowding out identification of the unusual items
DURHAM, NC -- A smartphone app that turns gamers into airport baggage screeners is showing that finding weapons and other illegal items isn't all that easy, ...
Development near Oregon, Washington public forests
2013-12-04
Development near Oregon, Washington public forests
Private development along the edges of most public forests in Oregon and Washington more than doubled since the 1970s, a new study conducted by the U.S. Forest Service Pacific's ...
Sounding tall
2013-12-04
Sounding tall
Listeners can distinguish the voices of tall versus short people, according to a study presented at a meeting of the Acoustical Society of America in San Francisco
SAN FRANCISCO, Nov. 27, 2013 – Our voice can reveal a lot about us: our age, our ...
'Spooky action' builds a wormhole between 'entangled' quantum particles
2013-12-04
'Spooky action' builds a wormhole between 'entangled' quantum particles
Quantum entanglement, a perplexing phenomenon of quantum mechanics that Albert Einstein once referred to as "spooky action at a distance," could be even spookier than Einstein perceived.
Physicists ...
Expedition yields unexpected clues to ocean mysteries
2013-12-04
Expedition yields unexpected clues to ocean mysteries
UH geoscientist leads international drilling mission to lower crust of pacific
HOUSTON, Dec. 3, 2013 – A University of Houston (UH) geoscientist and his colleagues are revealing new discoveries about the Earth's development, ...
Children's National researcher authors study on pediatric brain stem tumors
2013-12-04
Children's National researcher authors study on pediatric brain stem tumors
Washington, DC— Children's National researcher, Javad Nazarian, PhD, authored a new study entitled, "Comparative Multidimensional Molecular Analyses of Pediatric ...
Agricultural fires in Ecuador Dec. 3, 2013
2013-12-04
Agricultural fires in Ecuador Dec. 3, 2013
The fires (outlined in red) in this image of Ecuador taken by the Aqua satellite are most likely agricultural in nature. The location, widespread nature, and number of fires suggest that these fires were deliberately ...
Dispelling an urban legend, new study shows who uses emergency departments frequently
2013-12-04
Dispelling an urban legend, new study shows who uses emergency departments frequently
While it has often been said that the most frequent users of overburdened hospital emergency departments are mentally ill substance abusers, a study out today (Dec. 3) by researchers ...
Toxigenic C. difficile resides harmlessly in infants, poses risk to adults
2013-12-04
Toxigenic C. difficile resides harmlessly in infants, poses risk to adults
Infants and toddlers frequently carry toxigenic Clostridium difficile, usually with no harm to themselves, but can serve as a reservoir and spread the bacteria to adults in whom it can ...
Assessing dangerous climate change and call for climate change response papers
2013-12-04
Assessing dangerous climate change and call for climate change response papers
PLOS ONE publishes "Assessing Dangerous Climate Change: Required Reductions of Carbon Emissions to Protect Young People, Future Generations and Nature" from James Hansen and ...
LAST 30 PRESS RELEASES:
Team of Prof. Woo Young Jang Department of Orthopedic Surgery, KU Anam Hospital wins the Best Paper Award from the Korean Musculoskeletal Tumor Society
Terasaki Institute for Biomedical Innovation announces recipients of inaugural Keith Terasaki Mid-Career Innovation Award
The impact of liver graft preservation method on longitudinal gut microbiome changes following liver transplant
Cardiovascular health risks continue to grow within Black communities, action needed
ALS survival may be cut short by living in disadvantaged communities
No quantum exorcism for Maxwell's demon (but it doesn't need one)
Balancing the pressure: How plant cells protect their vacuoles
Electronic reporting of symptoms by cancer patients can improve quality of life and reduce emergency visits
DNA barcodes and citizen science images map spread of biocontrol agent for control of major invasive shrub
Pregnancy complications linked to cardiovascular disease in the family
Pancreatic cancer immune map provides clues for precision treatment targeting
How neighborhood perception affects housing rents: A novel analytical approach
Many adults report inaccurate beliefs about risks and benefits of home firearm access
Air pollution impacts an aging society
UC Davis researchers achieve total synthesis of ibogaine
Building better biomaterials for cancer treatments
Brain stimulation did not improve impaired motor skills after stroke
Some species of baleen whales avoid attracting killer whales by singing too low to be heard
Wasteful tests before surgery: Study shows how to reduce them safely
UCalgary researchers confirm best approach for stroke in medium-sized blood vessels
Nationwide, 34 local schools win NFL PLAY 60 grants to help students move more
New software developed at Wayne State University will help study chemical and biological systems
uOttawa study unveils new insights into how neural stem cells are activated in the adult human brain
Cystic fibrosis damages the immune system early on
Novel ‘living’ biomaterial aims to advance regenerative medicine
Warding off superbugs with a pinch of turmeric
Ophthalmic complications in patients on antidiabetic GLP-1 medications are concerning neuro-ophthalmologists
Physicians committee research policy director speaks today at hearing on taxpayer funded animal cruelty
New technology lights way for accelerating coral reef restoration
Electroencephalography may help guide treatments for language disorders
[Press-News.org] Gene therapy bolsters enzyme activity to combat Alzheimer's disease in miceSt. Jude Children's Research Hospital scientists identify enzyme that could lead to better diagnosis and treatment of Alzheimer's disease and related disorders